XML 21 R46.htm IDEA: XBRL DOCUMENT v2.4.1.9
OTHER CURRENT LIABILITIES (Details) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Other Liabilities Disclosure [Abstract]    
Accrued clinical trial costs $ 1,706,542txmd_AccruedClinicalTrialCostsCurrent $ 665,782txmd_AccruedClinicalTrialCostsCurrent
Accrued payroll, bonuses and commission costs 814,205us-gaap_AccruedSalariesCurrent 941,313us-gaap_AccruedSalariesCurrent
Accrued vacation costs 442,430us-gaap_AccruedVacationCurrent 256,920us-gaap_AccruedVacationCurrent
Accrued legal and accounting expense 276,470us-gaap_AccruedProfessionalFeesCurrent 224,550us-gaap_AccruedProfessionalFeesCurrent
Other accrued expenses 185,965us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent [1] 177,900us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent [1]
Allowance for wholesale distributor fees 160,503txmd_AllowanceForWholesaleDistributorFeesCurrent 306,303txmd_AllowanceForWholesaleDistributorFeesCurrent
Accrued royalties 72,710us-gaap_AccruedRoyaltiesCurrent 52,188us-gaap_AccruedRoyaltiesCurrent
Allowance for coupons and returns 90,446txmd_SalesDiscountsReturnsAndAllowancesGoods1 126,233txmd_SalesDiscountsReturnsAndAllowancesGoods1
Accrued rent 91,368us-gaap_AccruedRentCurrent   
Accrued financing costs    850,000txmd_AccruedFinancingCostsCurrent
TOTAL OTHER CURRENT LIABILITIES $ 3,840,639us-gaap_OtherLiabilitiesCurrent $ 3,601,189us-gaap_OtherLiabilitiesCurrent
[1] In June 2008, we declared and paid a special dividend of $0.40 per share of our Common Stock to all stockholders of record as of June 10, 2008, of which $41,359 remained unclaimed by certain stockholders at both December 31, 2014 and 2013.